The future of carcinogenicity testing is headed towards more ethical, cost-effective, and human-relevant approaches. Advances in toxicogenomics, bioinformatics, and high-throughput screening are paving the way for innovative testing strategies. These advancements aim to reduce animal use, improve prediction accuracy, and provide deeper insights into cancer mechanisms.
